Current Issues in Molecular Biology (Oct 2022)

SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk

  • Martha P. Gallegos-Arreola,
  • Ramiro Ramírez-Patiño,
  • Josefina Y. Sánchez-López,
  • Guillermo M. Zúñiga-González,
  • Luis E. Figuera,
  • Jorge I. Delgado-Saucedo,
  • Belinda C. Gómez-Meda,
  • Mónica A. Rosales-Reynoso,
  • Ana M. Puebla-Pérez,
  • María L. Lemus-Varela,
  • Asbiel F. Garibaldi-Ríos,
  • Nayely A. Marín-Domínguez,
  • Diana P. Pacheco-Verduzco,
  • Emaan A. Mohamed-Flores

DOI
https://doi.org/10.3390/cimb44110355
Journal volume & issue
Vol. 44, no. 11
pp. 5221 – 5233

Abstract

Read online

The superoxide dismutase (SOD) is the principal antioxidant defense system in the body that is activated by a reactive oxygen species. Some variants of the SOD2 gene have been associated with cancer. The rs4880 variant was determined by PCR real-time and the rs5746136 variant by PCR-RFLP in healthy subjects and in breast cancer (BC) patients. The rs4880 and rs5746136 variants were associated with BC susceptibility when BC patients and the control group were compared for the CT, TT, CTCC, and the T alleles (p CT genotype of the rs4880 variant showed significant statistical differences in patients and controls aged ≤ 45 years old, and with hormonal consumption (p CTTT genotype and obesity, the presence of DM2-SAH, and a non-chemotherapy response (p p TT, TC, and CTTT genotypes, respectively. The haplotype T/T (OR 1.98; 95% CI 1.20–3.26, p = 0.005) was observed to be a risk factor for BC. The rs4880 and rs5746136 variants in the SOD2 gene were associated with BC susceptibility.

Keywords